sábado, 5 de abril de 2014

Preventing Chronic Disease | Program Participation and Blood Pressure Improvement in the Heart of New Ulm Project, Minnesota, 2009–2011 - CDC

full-text ►

Preventing Chronic Disease | Program Participation and Blood Pressure Improvement in the Heart of New Ulm Project, Minnesota, 2009–2011 - CDC



Preventing Chronic Disease Logo

Image of eCard



Program Participation and Blood Pressure Improvement in the Heart of New Ulm Project, Minnesota, 2009–2011

Arthur Sillah, MPH; Abbey C. Sidebottom, MPH; Jackie L. Boucher, MS, RD; Raquel Pereira, MS, RD, LD; Jeffrey J. VanWormer, PhD

Suggested citation for this article: Sillah A, Sidebottom AC, Boucher JL, Pereira R, VanWormer JJ. Program Participation and Blood Pressure Improvement in the Heart of New Ulm Project, Minnesota, 2009–2011. Prev Chronic Dis 2014;11:130205. DOI:http://dx.doi.org/10.5888/pcd11.130205External Web Site Icon.
PEER REVIEWED

Abstract

Introduction
The Heart of New Ulm (HONU) Project is a community-based heart disease prevention intervention that delivers various component programs through health care, work sites, and the community. We examined the association between HONU program participation and blood pressure (BP) control over the first 2 years of the project.
Methods
The sample included residents aged 40 to 79 years from the target zip code who attended a heart health screening at baseline (2009) and again at follow-up (2011). BP control was defined as achieving or maintaining a BP less than 140/90 mm Hg in 2011.
Results
BP improvements were observed in the sample: 81.7% of those who had controlled BP in 2009 maintained controlled BP 2 years later, and 52.4% of those with uncontrolled BP at baseline had controlled BP 2 years later (mean [SD] change in systolic BP, −10.6 mm Hg [20.8]). In the final adjusted model, participation in any 2 component programs of the HONU Project was associated with significantly higher odds of BP control among those with uncontrolled BP at baseline (n = 374). Participation in any component of the HONU Project among those with uncontrolled BP was associated with significant BP improvement compared with no participation.
Conclusions
The clinical, work site, and community education and behavioral programs (eg, healthful diet or physical activity) delivered as part of a population-level heart disease prevention intervention were associated with meaningful BP improvements over 2 years among those with uncontrolled BP at baseline.


Author Information

Corresponding Author: Arthur Sillah, MPH, Allina Health, Division of Applied Research Center for Healthcare Research and Innovation, Mail Route 10105; 2925 Chicago Ave, Minneapolis, MN 55407. Telephone: 651-271-8091. E-mail: arthur.sillah@allina.com.
Author Affiliations: Abbey C. Sidebottom, Allina Health, Minneapolis, Minnesota; Jackie L. Boucher, Raquel Pereira, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota; Jeffrey J. VanWormer, Epidemiology Research Center, Marshfield Clinic Research Foundation, Marshfield, Wisconsin.

References

  1. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics — 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119(3):480–6. Erratum in Circulation 2009;119(3):e182. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  2. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med 2007;356(23):2388–98. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  3. Roger VL, Jacobsen SJ, Weston SA, Goraya TY, Killian J, Reeder GS, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med 2002;136(5):341–8. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  4. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics — 2012 update: a report from the American Heart Association. Circulation 2012;125(1):e2–220. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  5. Colleran KM, Richards A, Shafer K. Disparities in cardiovascular disease risk and treatment: demographic comparison. J Investig Med 2007;55(8):415–22. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  6. Yoon SS, Ostchega Y, Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999–2008. NCHS Data Brief 2010;(48):1–8. PubMedExternal Web Site Icon
  7. Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 2000;85(2):251–5. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  8. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992;152(1):56–64. CrossRefExternal Web Site IconPubMedExternal Web Site Icon
  9. Farquhar JW, Fortmann SP, Flora JA, Taylor CB, Haskell WL, Williams PT, et al. Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project. JAMA 1990;264(3):359–65. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  10. Winkleby MA, Feldman HA, Murray DM. Joint analysis of three U.S. community intervention trials for reduction of cardiovascular disease risk. J Clin Epidemiol 1997;50(6):645–58. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  11. Stoddard AM, Palombo R, Troped PJ, Sorensen G, Will JC. Cardiovascular disease risk reduction: the Massachusetts WISEWOMAN project. J Womens Health (Larchmt) 2004;13(5):539–46. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  12. VanWormer JJ, Johnson PJ, Pereira RF, Boucher JL, Britt HR, Stephens CW, et al. The Heart of New Ulm Project: using community-based cardiometabolic risk factor screenings in a rural population health improvement initiative. Popul Health Manag 2012;15(3):135–43. CrossRefExternal Web Site IconPubMedExternal Web Site Icon
  13. Boucher JL, Pereira RF, Graham KJ, Pettingill RR, Toscano JV, Henry TD. The Heart of New Ulm: a vision for the future. J Cardiovasc Transl Res 2008;1(4):310–6. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  14. Mittelmark MB, Luepker RV, Jacobs DR, Bracht NF, Carlaw RW, Crow RS, et al. Community-wide prevention of cardiovascular disease: education strategies of the Minnesota Heart Health Program. Prev Med 1986;15(1):1–17. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  15. Puska P, Nissinen A, Tuomilehto J, Salonen JT, Koskela K, McAlister A, et al. The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health 1985;6:147–93. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  16. McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q 1988;15(4):351–77. CrossRefExternal Web Site IconPubMedExternal Web Site Icon
  17. Vale MJ, Jelinek MV, Best JD, Dart AM, Grigg LE, Hare DL, et al. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease. Arch Intern Med 2003;163(22):2775–83. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  18. Blake H, Lloyd S. Influencing organisational change in the NHS: lessons learned from workplace wellness initiatives in practice. Qual Prim Care 2008;16(6):449–55. PubMedExternal Web Site Icon
  19. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153(2):154–83. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  20. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013;310(9):959–68. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  21. Egan BM, Zhao Y, Axon RN. US trends in prevalence awareness and control of hypertension, 1988–2008. JAMA 2010;303(20):2043–50. CrossRefExternal Web Site IconPubMedExternal Web Site Icon
  22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206–52. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  23. ACCORD Study Group, Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362(17):1575–85. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  24. Padwal RS, Hemmelgarn BR, Khan NA, Grover S, McKay DW, Wilson T, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 — blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2009;25(5):279–86.CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  25. US Census Bureau. American Community Survey, 2010 American Community Survey 1-year estimates; generated using American FactFinder. http://factfinder2.census.gov. Accessed February 13, 2014.
  26. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. Circulation 2012;126(17):2105–14. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  27. Stamler J, Rose G, Stamler R, Elliott P, Dyer A, Marmot M. INTERSALT study findings. Public health and medical care implications. Hypertension 1989;14(5):570–7. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  28. VanWormer JJ, Boucher JL, Thygeson NM, Graham KJ. The Heart of New Ulm Project: community systems model of prevention shows early indications of reducing event and mortality rates of acute myocardial infarction. J Am Coll Cardiol 2011;57(14 Suppl):E1211. CrossRefExternal Web Site Icon
  29. Barry LC, Lichtman JH, Spertus JA, Rumsfeld JS, Vaccarino V, Jones PG, et al. Patient satisfaction with treatment after acute myocardial infarction: role of psychosocial factors. Psychosom Med 2007;69(2):115–23. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  30. Polo Friz H, Facchetti R, Primitz L, Beltrame L, Galbiati V, Ricioppo A, et al. Simultaneous validation of the SunTech 247 diagnostic station blood pressure measurement device according to the British Hypertension Society protocol, the International Protocol and the Association for the Advancement of Medical Instrumentation standards. Blood Press Monit 2009;14(5):222–7. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon

No hay comentarios: